he observation of lower mean white blood cell (WBC) counts among individuals of African ancestry compared with those of European ancestry is well established. [1][2][3][4] The clinical finding of low WBC counts among healthy individuals of African ancestry is variably designated benign ethnic neutropenia and is not associated with an increased risk of infection. [5][6][7] This phenomenon is attributed, in large part, to homozygosity for the rs2814778-C variant in the promoter of ACKR1 (OMIM 613665) gene. Loss of expression of ACKR1 on cell surfaces may lead to relative neutropenia attributable to sequestration of neutrophils in peripheral tissues, including the spleen. 8 This variant is common (allele frequency, 0.96) among populations in sub-Saharan Africa but uncommon (allele frequency, 0.006) among White populations of European ancestry. [9][10][11][12][13] Approximately 63% of African American individuals, who are of mixed European and African ancestries, have the CC genotype and would be anticipated to have benign ethnic neutropenia. 9 Because reference ranges of normal values for WBC counts do not account for genotype, persons with the rs2814778-CC genotype are more likely to have a WBC count that falls below the reference range. Although many practitioners are aware of IMPORTANCE Up to two-thirds of African American individuals carry the benign rs2814778-CC genotype that lowers total white blood cell (WBC) count.OBJECTIVE To examine whether the rs2814778-CC genotype is associated with an increased likelihood of receiving a bone marrow biopsy (BMB) for an isolated low WBC count.
DESIGN, SETTING, AND PARTICIPANTSThis retrospective genetic association study assessed African American patients younger than 90 years who underwent a BMB at